VIR Biotechnology
VIR Biotechnology has identified multiple human monoclonal antibody (mAb) development candidates that neutralize SARS-CoV-2, the virus responsible for COVID-19
Rankings by
National Ranking315th
in United States Regional Ranking356th
in North America and Caribbean Global Ranking863rd
worldwide